West Lafayette, IN, United States of America

Stephan D Parent

USPTO Granted Patents = 49 

 

Average Co-Inventor Count = 4.8

ph-index = 7

Forward Citations = 245(Granted Patents)


Location History:

  • West Lafayette, MA (US) (2012)
  • W. Lafayette, IN (US) (2012 - 2014)
  • Waltham, MA (US) (2015)
  • South San Francisco, CA (US) (2016 - 2022)
  • West Lafayette, IN (US) (2009 - 2024)

Company Filing History:

goldMedal6 out of 57 
 
Global Blood Therapeutics, Inc.
 patents
silverMedal6 out of 63 
 
Salix Pharmaceuticals, Inc.
 patents
bronzeMedal4 out of 7 
 
Ferrokin Biosciences, Inc.
 patents
44 out of 6 
 
Il Yang Pharmaceutical Company, Ltd.
 patents
53 out of 61 
 
Reata Pharmaceuticals, Inc.
 patents
63 out of 85 
 
Vitae Pharmaceuticals, Inc.
 patents
73 out of 14 
 
Aeromics, Inc.
 patents
82 out of 1,500 
 
Astrazeneca Ab
 patents
92 out of 415 
 
Nektar Therapeutics
 patents
102 out of 39 
 
Ambit Biosciences Corporation
 patents
112 out of 1,149 
 
Vertex Pharmaceuticals, Inc.
 patents
122 out of 1,970 
 
Amgen Inc.
 patents
131 out of 6 
 
Noven Therapeutics, LLC
 patents
141 out of 1 
 
Mutual Pharamaceutical Company, Inc.
 patent
151 out of 11 
 
Tetra Discovery Partners, LLC
 patents
161 out of 37 
 
Photocure Asa
 patents
171 out of 1 
 
Varda Space Industries, Inc.
 patent
181 out of 5 
 
Canna Chemistries LLC
 patents
191 out of 173 
 
Exelixis, Inc.
 patents
201 out of 53 
 
Chdi Foundation, Inc.
 patents
211 out of 23 
 
Takeda Pharmaceuticals U.s.a., Inc.
 patents
221 out of 37 
 
Telik, Inc.
 patents
231 out of 29 
 
Mutual Pharmaceutical Company, Inc.
 patents
241 out of 17 
 
Kalypsys, Inc.
 patents
where one patent can have more than one assignee

Years Active: 2009-2025

Loading Chart...
Loading Chart...
49 patents (USPTO):

Title: The Innovative Journey of Stephan D. Parent in the Pharmaceutical Industry

Introduction: Stephan D. Parent is a distinguished inventor based in West Lafayette, Indiana, with an impressive portfolio of 43 patents. His innovative contributions significantly advance pharmaceutical research and development, particularly in the realm of crystallography and kinase inhibitors.

Latest Patents: Among his latest inventions, Stephan D. Parent has developed patents related to crystals of 2-{[3,5-bis(trifluoromethyl)phenyl]carbamoyl}-4-chlorophenyl dihydrogen phosphate. These inventions include compositions comprising these crystals and methods for their production and use. Additionally, he has focused on crystalline forms and salt forms of a kinase inhibitor, specifically a c-Met inhibitor known as Compound 1. This patent encompasses various crystalline forms, salts, and pharmaceutical compositions involving these solid polymorphs, along with methods for treating diseases mediated by protein kinases.

Career Highlights: Throughout his career, Stephan D. Parent has made substantial strides in the pharmaceutical industry, notably with companies like Salix Pharmaceuticals and Global Blood Therapeutics. His work has played a crucial role in the development of innovative therapeutic solutions.

Collaborations: Stephan has collaborated with notable professionals, including David T. Jonaitis and Travis Lee Houston. Their collective efforts have contributed to the successful advancement of several patentable inventions in the field of medicinal chemistry.

Conclusion: Stephan D. Parent's journey as an inventor showcases his dedication to pushing the boundaries of pharmaceutical research. With a solid record of patents and professional collaborations, he continues to make significant impacts in the industry, paving the way for innovative treatments and therapeutic advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…